Menu
Back to Journals » Biologics: Targets and Therapy » Volume 17
ESCI
SJR OA
CiteScore
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (481)
- Volume 17, 2023 (2)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 17, 2023
Research Letter
Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
van Leeuwen JR, Popov T, Obergfell A, Rabelink TJ, Teng YKO
Biologics: Targets and Therapy 2023, 17:11-14
Published Date: 25 January 2023
Original Research
Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices
Haroon MM, Hegazy GA, Hassanien MA, Shaker O, Hussein WH
Biologics: Targets and Therapy 2023, 17:1-9
Published Date: 18 January 2023